Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

No reported Common Stock figures are available to summarize.

Common Stock history

Currency unavailable · from the balance sheet

No Common Stock data reported for this period type.

Common Stock vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Common Stock for KARD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NAMSNewAmsterdam Pharma Company N.V.Jun 2026$14.74M USD+5.1%+12.4%2.1%
CYTKCytokinetics, IncorporatedJun 2026$138K USD+16.0%+9.4%0.0%
IKTInhibikase Therapeutics, Inc.Mar 2026$132.03K USD+77.6%+214.7%0.1%
TNYATenaya Therapeutics, Inc.Mar 2026$21K USD+31.3%+44.2%0.0%
RNAAtrium Therapeutics, Inc.Mar 2026$16K USD——0.0%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+23.6%+28.3%0.0%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.